Close Menu

NEW YORK – Ginkgo Bioworks today announced the launch of a $350 million private investment vehicle for funding spinoffs from the firm. 

Dubbed the Ferment Consortium, the fund is supported by a commitment from Ginkgo's current major investors including Viking Global Investors, General Atlantic, and Bill Gates' Cascade Investment. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.